# Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma

> **NCT02030483** · PHASE1 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 9 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Palbociclib
- **DRUG:** Dexamethasone
- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT02030483
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** The company providing one of the study drugs withdrew its support due to low enrollment. Therefore, we had to close the study due to lack of funding.
- **Last updated:** 2018-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02030483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02030483, "Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02030483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*